Feb 25, 2020
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $0.43 to $0.30.
The split itself did not change the total investment value.
Generex Biotechnology Corporation (GNBT) trades on the Other OTC in the Biotechnology industry.
Generex Biotechnology Corporation company overviewThe latest split shown was on February 25, 2020. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
This history records 6 forward splits between December 3, 2018 and February 25, 2020.